We found that RNAi-mediated SHMT silencing promotes the progression of Ras<sup>V12</sup>Dlg<sup>RNAi</sup> cancers by impairing thymidylate biosynthesis in the folate pathway. The gene discussed is SHMT1; the disease is cancer.